68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer.
Goda G KalinauskaiteCarolin SengerAnne KlugeChristian FurthMarkus KufeldIngeborg TinhoferVolker BudachMarcus BeckAlexandra HochreiterArne GrünCarmen StrombergerPublished in: PloS one (2020)
For patients with OMPC, SBRT might be used as an alternative to ADT. This way, the start/escalation of palliative ADT and its side effects can be deferred. Metastases treated with PSMA-PET/CT-based SFRS reached excellent LC with minimal toxicity. Low PSA levels and longer TTM predict elongated TFFS.
Keyphrases
- pet ct
- prostate cancer
- radical prostatectomy
- radiation therapy
- early stage
- positron emission tomography
- brain metastases
- locally advanced
- palliative care
- oxidative stress
- radiation induced
- simultaneous determination
- open label
- small cell lung cancer
- advanced cancer
- computed tomography
- clinical trial
- squamous cell carcinoma
- randomized controlled trial
- tandem mass spectrometry
- study protocol
- double blind